Data Presented at UEG Week 2023 Further Support the Potential of Celltrion’s Investigational Subcutaneous Infliximab CT-P13 SC in the Treatment of Inflammatory Bowel Disease
The latest clinical trial data for subcutaneous (SC) infliximab (CT-P13 SC), presented at the United…